| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ADGRG5 OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B OR8S1 OR1C1 TAS2R38 ADGRE2 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 GPR174 GPR62 OR6C70 ADGRE3 ADGRE4P SCTR C3AR1 OR7G3 OR7G2 VN1R3 GPR26 OR4C6 MRGPRE OR1F12P GPR88 RGR CRHR2 SORCS3 ACKR1 CXCR1 CXCR2 | 6.00e-12 | 884 | 238 | 38 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ADGRG5 OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B OR8S1 OR1C1 TAS2R38 ADGRE2 OR2T4 OR1J4 SLC22A17 OR1L3 OR1L1 TAS2R5 GPR174 GPR62 OR6C70 ADGRE3 PKD1 ADGRE4P SCTR ANTXR1 C3AR1 OR7G3 OR7G2 VN1R3 GPR26 OR4C6 MRGPRE OR1F12P GPR88 RGR CRHR2 TLR2 SORCS3 FCRL4 ACKR1 CXCR1 CXCR2 | 3.07e-09 | 1353 | 238 | 43 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 1.77e-05 | 431 | 238 | 17 | GO:0004984 |
| GeneOntologyMolecularFunction | interleukin-8 receptor activity | 1.41e-04 | 2 | 238 | 2 | GO:0004918 | |
| GeneOntologyMolecularFunction | interleukin-8 binding | 4.21e-04 | 3 | 238 | 2 | GO:0019959 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 4.21e-04 | 3 | 238 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | SLC38A9 HERC1 DOCK6 PREX1 VAV2 CCZ1B SH2D3A ARFGEF1 ARFGEF3 CCZ1 | 4.73e-04 | 231 | 238 | 10 | GO:0005085 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADGRG5 OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B LRRK2 OR8S1 OR1C1 TAS2R38 ADGRE2 OR2T4 ZDHHC3 OR1J4 ADCY1 ADCY5 OR1L3 OR1L1 TAS2R5 GPR174 GPR62 OR6C70 ADGRE3 ADGRE4P SCTR FGF8 C3AR1 OR7G3 OR7G2 PREX1 VN1R3 CALCA GPR26 OR4C6 MRGPRE OR1F12P ZDHHC7 GPR88 RGR CRHR2 SORCS3 ACKR1 HTT CXCR1 CXCR2 | 1.46e-11 | 1395 | 235 | 47 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 PIEZO1 OR8S1 OR1C1 TAS2R38 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 OR6C70 PKD1 STRC OR7G3 OR7G2 STRCP1 CALCA OR4C6 OR1F12P GPR88 RGR TLR2 | 6.39e-08 | 722 | 235 | 27 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 TAS2R38 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 OR6C70 STRC OR7G3 OR7G2 STRCP1 CALCA OR4C6 OR1F12P | 9.56e-07 | 582 | 235 | 22 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 TAS2R38 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P TLR2 | 2.63e-06 | 524 | 235 | 20 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 TAS2R38 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 3.24e-06 | 485 | 235 | 19 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 TAS2R38 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 OR6C70 OR7G3 OR7G2 VN1R3 OR4C6 OR1F12P | 5.01e-06 | 547 | 235 | 20 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 1.02e-05 | 432 | 235 | 17 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 2.62e-05 | 465 | 235 | 17 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception | OR7G1 OR5T1 OR5M10 GJD2 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 TAS2R38 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 OR6C70 STRC OR7G3 OR7G2 RABGGTA CCN3 STRCP1 VN1R3 CALCA OR4C6 OR1F12P RGR RP1L1 | 3.79e-05 | 1072 | 235 | 28 | GO:0007600 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | ADGRG5 ADGRE2 ADCY1 ADCY5 GPR62 ADGRE3 ADGRE4P SCTR CALCA GPR26 | 7.07e-05 | 191 | 235 | 10 | GO:0007189 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | ADGRG5 ADGRE2 ADCY1 ADCY5 GPR62 ADGRE3 ADGRE4P SCTR CALCA GPR26 GPR88 CRHR2 | 1.15e-04 | 286 | 235 | 12 | GO:0007188 |
| GeneOntologyBiologicalProcess | interleukin-8-mediated signaling pathway | 1.29e-04 | 2 | 235 | 2 | GO:0038112 | |
| GeneOntologyCellularComponent | secretory granule membrane | TMC6 CD109 ITGAM NBEAL2 ADGRE3 C3AR1 UBR4 LAIR1 TLR2 SERPINA5 GAA DGAT1 CXCR1 CXCR2 | 2.79e-05 | 329 | 239 | 14 | GO:0030667 |
| GeneOntologyCellularComponent | inner dynein arm | 1.67e-04 | 10 | 239 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.75e-04 | 25 | 239 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 1.88e-04 | 73 | 239 | 6 | GO:0070821 | |
| HumanPheno | Reduced sperm motility | 1.57e-07 | 69 | 65 | 9 | HP:0012207 | |
| HumanPheno | Abnormal sperm motility | 1.23e-05 | 115 | 65 | 9 | HP:0012206 | |
| HumanPheno | Abnormal sperm physiology | 1.23e-05 | 115 | 65 | 9 | HP:0034809 | |
| MousePheno | increased eosinophil cell number | SPNS3 ITGAM FBXL18 HERC1 HERC6 LAIR1 LAIR2 TRAPPC8 RASAL3 PRKDC CXCR2 | 1.47e-05 | 178 | 175 | 11 | MP:0005011 |
| MousePheno | abnormal eosinophil morphology | SPNS3 ITGAM LYST FBXL18 C3AR1 HERC1 HERC6 LAIR1 LAIR2 TRAPPC8 RASAL3 PRKDC CXCR2 | 2.39e-05 | 260 | 175 | 13 | MP:0005061 |
| Domain | ARM-type_fold | ATR SARM1 LRRK2 CUL9 LYST URB1 PIK3C2B XPO6 NBEAL2 MMS19 UBR4 ARFGEF1 HUWE1 ARFGEF3 THADA HEATR6 MROH1 PRKDC STKLD1 HTT | 9.52e-09 | 339 | 232 | 20 | IPR016024 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 GPR174 GPR62 OR6C70 C3AR1 OR7G3 OR7G2 VN1R3 GPR26 OR4C6 MRGPRE OR1F12P GPR88 RGR CXCR1 CXCR2 | 3.27e-08 | 685 | 232 | 28 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 GPR174 GPR62 OR6C70 C3AR1 OR7G3 OR7G2 VN1R3 GPR26 OR4C6 MRGPRE OR1F12P GPR88 RGR CXCR1 CXCR2 | 3.93e-08 | 691 | 232 | 28 | PS50262 |
| Domain | GPCR_Rhodpsn | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 GPR174 GPR62 OR6C70 C3AR1 OR7G3 OR7G2 VN1R3 GPR26 OR4C6 MRGPRE OR1F12P GPR88 RGR CXCR1 CXCR2 | 4.05e-08 | 692 | 232 | 28 | IPR000276 |
| Domain | 7tm_1 | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 GPR174 GPR62 OR6C70 C3AR1 OR7G3 OR7G2 GPR26 OR4C6 MRGPRE OR1F12P GPR88 RGR CXCR1 CXCR2 | 9.66e-08 | 677 | 232 | 27 | PF00001 |
| Domain | GPCR_Rhodpsn_7TM | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 AVPR1B OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 GPR174 GPR62 OR6C70 C3AR1 OR7G3 OR7G2 GPR26 OR4C6 MRGPRE GPR88 RGR CXCR1 CXCR2 | 2.88e-07 | 670 | 232 | 26 | IPR017452 |
| Domain | ARM-like | ATR SARM1 LRRK2 CUL9 XPO6 NBEAL2 MMS19 ARFGEF1 HUWE1 HEATR6 MROH1 PRKDC STKLD1 HTT ARMH4 | 1.52e-06 | 270 | 232 | 15 | IPR011989 |
| Domain | Olfact_rcpt | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 9.00e-06 | 393 | 232 | 17 | IPR000725 |
| Domain | 7tm_2 | 3.47e-05 | 50 | 232 | 6 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.47e-05 | 50 | 232 | 6 | PS00650 | |
| Domain | GPS | 5.87e-05 | 34 | 232 | 5 | SM00303 | |
| Domain | GPS | 6.78e-05 | 35 | 232 | 5 | PF01825 | |
| Domain | GPS | 7.80e-05 | 36 | 232 | 5 | PS50221 | |
| Domain | GPS | 8.93e-05 | 37 | 232 | 5 | IPR000203 | |
| Domain | GPCR_2_secretin-like | 9.85e-05 | 60 | 232 | 6 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.08e-04 | 61 | 232 | 6 | PS50261 | |
| Domain | - | ATR SARM1 LRRK2 CUL9 XPO6 MMS19 ARFGEF1 HEATR6 MROH1 PRKDC HTT | 1.09e-04 | 222 | 232 | 11 | 1.25.10.10 |
| Domain | Chemokine_CXCR_1/2 | 1.54e-04 | 2 | 232 | 2 | IPR000174 | |
| Domain | DUF1712 | 1.54e-04 | 2 | 232 | 2 | PF08217 | |
| Domain | DUF1712_fun | 1.54e-04 | 2 | 232 | 2 | IPR013176 | |
| Domain | HEAT_REPEAT | 2.33e-04 | 70 | 232 | 6 | PS50077 | |
| Domain | HEAT | 3.14e-04 | 48 | 232 | 5 | PF02985 | |
| Domain | RHIM | 4.57e-04 | 3 | 232 | 2 | PF12721 | |
| Domain | RHIM_dom | 4.57e-04 | 3 | 232 | 2 | IPR025735 | |
| Domain | GPCR_2_EMR1-like_rcpt | 4.57e-04 | 3 | 232 | 2 | IPR001740 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.22e-04 | 14 | 232 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.22e-04 | 14 | 232 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.22e-04 | 14 | 232 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.22e-04 | 14 | 232 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.22e-04 | 14 | 232 | 3 | IPR011704 | |
| Domain | MT | 6.22e-04 | 14 | 232 | 3 | PF12777 | |
| Domain | AAA_8 | 6.22e-04 | 14 | 232 | 3 | PF12780 | |
| Domain | AAA_5 | 6.22e-04 | 14 | 232 | 3 | PF07728 | |
| Domain | HEAT | 7.60e-04 | 58 | 232 | 5 | IPR000357 | |
| Domain | DHC_fam | 7.71e-04 | 15 | 232 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.71e-04 | 15 | 232 | 3 | PF03028 | |
| Domain | PI3/4_kinase_CS | 7.71e-04 | 15 | 232 | 3 | IPR018936 | |
| Domain | Dynein_heavy_dom | 7.71e-04 | 15 | 232 | 3 | IPR004273 | |
| Domain | GPCR_2_secretin-like_CS | 8.03e-04 | 34 | 232 | 4 | IPR017983 | |
| Domain | GPCR_2-like | 8.87e-04 | 60 | 232 | 5 | IPR017981 | |
| Domain | DCB_dom | 9.07e-04 | 4 | 232 | 2 | IPR032629 | |
| Domain | Peptidase_C12 | 9.07e-04 | 4 | 232 | 2 | PF01088 | |
| Domain | Sec7_C | 9.07e-04 | 4 | 232 | 2 | IPR015403 | |
| Domain | DUF1981 | 9.07e-04 | 4 | 232 | 2 | PF09324 | |
| Domain | Peptidase_C12_UCH | 9.07e-04 | 4 | 232 | 2 | IPR001578 | |
| Domain | UCH_1 | 9.07e-04 | 4 | 232 | 2 | PS00140 | |
| Domain | DCB | 9.07e-04 | 4 | 232 | 2 | PF16213 | |
| Domain | - | 9.07e-04 | 4 | 232 | 2 | 3.40.532.10 | |
| Domain | - | 9.40e-04 | 16 | 232 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 9.40e-04 | 16 | 232 | 3 | SM00146 | |
| Domain | PI3_PI4_kinase | 1.34e-03 | 18 | 232 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.34e-03 | 18 | 232 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.34e-03 | 18 | 232 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 1.34e-03 | 18 | 232 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.34e-03 | 18 | 232 | 3 | PS50290 | |
| Domain | MFS_dom | 1.44e-03 | 134 | 232 | 7 | IPR020846 | |
| Domain | FATC | 1.50e-03 | 5 | 232 | 2 | PF02260 | |
| Domain | PH_BEACH | 2.23e-03 | 6 | 232 | 2 | PF14844 | |
| Domain | FAT | 2.23e-03 | 6 | 232 | 2 | PS51189 | |
| Domain | FATC | 2.23e-03 | 6 | 232 | 2 | PS51190 | |
| Domain | FAT | 2.23e-03 | 6 | 232 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 2.23e-03 | 6 | 232 | 2 | IPR003151 | |
| Domain | FATC_dom | 2.23e-03 | 6 | 232 | 2 | IPR003152 | |
| Domain | PIK_FAT | 2.23e-03 | 6 | 232 | 2 | IPR014009 | |
| Domain | FATC | 2.23e-03 | 6 | 232 | 2 | SM01343 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 1.38e-05 | 417 | 172 | 17 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 OR6C70 OR7G3 OR7G2 OR4C6 | 2.24e-05 | 389 | 172 | 16 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR1C1 TAS2R38 OR2T4 OR1J4 OR1L3 OR1L1 TAS2R5 OR6C70 STRC OR7G3 OR7G2 OR4C6 OR1F12P | 9.74e-05 | 636 | 172 | 20 | M41834 |
| Pathway | WP_GPCRS_NONODORANT | AVPR1B ADGRE2 GPR174 ADGRE3 ADGRE4P SCTR C3AR1 RGR CRHR2 ACKR1 CXCR1 CXCR2 | 1.04e-04 | 266 | 172 | 12 | MM15843 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 PIEZO1 TMC6 CUL9 ZZEF1 BIRC6 LYST RYR1 BAP1 FAM20C URB1 DST MDN1 PIK3C2B XPO6 NBEAL2 CSAD PKD1 HERC1 DOCK6 PREX1 IQGAP3 SEMA4F ATP13A1 UBR4 ZDHHC7 GEMIN5 TTYH3 HUWE1 SYNE4 THADA TKFC AATK MROH1 DISP2 PRKDC HTT PPP1R16A | 3.35e-16 | 1105 | 240 | 38 | 35748872 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OR5M10 TOPAZ1 ITGAE ZZEF1 BIRC6 RYR1 FAM20C URB1 DST MDN1 PKD1 MTCL1 SEMA4F UBR4 DNAH2 ST3GAL4 HUWE1 SPATC1 GIMAP8 TM2D2 PRKDC CXCR2 | 1.08e-08 | 736 | 240 | 22 | 29676528 |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR2T4 OR1J4 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 1.26e-07 | 340 | 240 | 14 | 11875048 |
| Pubmed | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR2T4 OR1J4 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 1.26e-07 | 340 | 240 | 14 | 11802173 | |
| Pubmed | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR2T4 OR1J4 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 1.40e-07 | 343 | 240 | 14 | 32295537 | |
| Pubmed | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR8S1 OR2T4 OR1J4 OR6C70 OR7G3 OR7G2 OR4C6 OR1F12P | 1.55e-07 | 346 | 240 | 14 | 14611657 | |
| Pubmed | ATR XPO6 NBEAL2 MMS19 IQGAP3 ARFGEF1 ARFGEF3 EXOC5 THADA PRKDC | 6.47e-07 | 183 | 240 | 10 | 23956138 | |
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 24662979 | ||
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 18450748 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | SLC39A1 TMC6 ZDHHC3 ADCY1 SLC22A17 DST PKD1 ATP13A1 UBR4 NCKIPSD CERS6 RGR CRHR2 SLC32A1 AATK MFSD3 DGAT1 HTT | 1.99e-06 | 697 | 240 | 18 | 28298427 |
| Pubmed | Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. | 3.21e-06 | 5 | 240 | 3 | 19596237 | |
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 23550035 | ||
| Pubmed | OR7G1 OR5T1 OR5M10 OR5M1 OR1J1 OR7C1 OR1C1 OR2T4 OR1J4 OR1L3 OR1L1 OR7G3 OR7G2 OR4C6 OR1F12P | 6.27e-06 | 541 | 240 | 15 | 14983052 | |
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 14647991 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCKAP1 SARM1 SREBF2 RTN2 URB1 XPO6 MMS19 IQGAP3 DSG2 ATP13A1 AHCTF1 UBR4 DNAH2 ARFGEF1 CERS6 HUWE1 ARFGEF3 THADA PRKDC GAA | 1.00e-05 | 942 | 240 | 20 | 31073040 |
| Pubmed | Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. | 1.11e-05 | 7 | 240 | 3 | 19675137 | |
| Pubmed | 1.11e-05 | 7 | 240 | 3 | 20016852 | ||
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 1.27e-05 | 74 | 240 | 6 | 15081110 | |
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 29946151 | ||
| Pubmed | Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice. | 1.77e-05 | 8 | 240 | 3 | 30799265 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.85e-05 | 79 | 240 | 6 | 12679517 | |
| Pubmed | 2.64e-05 | 9 | 240 | 3 | 27257617 | ||
| Pubmed | 2.73e-05 | 125 | 240 | 7 | 19019335 | ||
| Pubmed | 3.57e-05 | 231 | 240 | 9 | 21048031 | ||
| Pubmed | 3.71e-05 | 179 | 240 | 8 | 19074885 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 3.76e-05 | 10 | 240 | 3 | 18160036 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ABCC3 NHSL2 SLC38A9 PAK4 ZDHHC3 BIRC6 XPO6 MMS19 HERC1 DSG2 TTYH3 TRAPPC8 THADA NOP14 ALG3 PPP1R16A | 4.54e-05 | 719 | 240 | 16 | 35337019 |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 4.59e-05 | 29 | 240 | 4 | 15203201 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 19584262 | ||
| Pubmed | Cell cycle-dependent expression and nucleolar localization of hCAP-H. | 4.74e-05 | 2 | 240 | 2 | 11694586 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 16987681 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 18209062 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 17354234 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 34260887 | ||
| Pubmed | DNA structure-specific priming of ATR activation by DNA-PKcs. | 4.74e-05 | 2 | 240 | 2 | 23897887 | |
| Pubmed | Crosstalk Between CD11b and Piezo1 Mediates Macrophage Responses to Mechanical Cues. | 4.74e-05 | 2 | 240 | 2 | 34630381 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 22268142 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 12966099 | ||
| Pubmed | The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. | 4.74e-05 | 2 | 240 | 2 | 20044480 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 12606724 | ||
| Pubmed | The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis. | 4.74e-05 | 2 | 240 | 2 | 28887430 | |
| Pubmed | Transposon-based mutagenesis identifies short RIP1 as an activator of NFkappaB. | 4.74e-05 | 2 | 240 | 2 | 18635966 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 8140728 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 23230212 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 27364547 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 22761909 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 22171941 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 21903993 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 27090786 | ||
| Pubmed | Mammalian class theta GST and differential susceptibility to carcinogens: a review. | 4.74e-05 | 2 | 240 | 2 | 11018744 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 8617493 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 26087179 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 15067069 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 20337891 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 34730557 | ||
| Pubmed | Sepsis-induced impairment of neutrophil chemotaxis on a microfluidic chip. | 4.74e-05 | 2 | 240 | 2 | 27016001 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 22496225 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 18344086 | ||
| Pubmed | The transcription factor NR4A3 controls CD103+ dendritic cell migration. | 4.74e-05 | 2 | 240 | 2 | 27820700 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 1639480 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 15356673 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 21555225 | ||
| Pubmed | Translocation of bacteria from the gastrointestinal tract in immunodeficient mice. | 4.74e-05 | 2 | 240 | 2 | 8709573 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 21254176 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 11564768 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 8962121 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 21915051 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 15100296 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 32470060 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 26631368 | ||
| Pubmed | Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. | 4.74e-05 | 2 | 240 | 2 | 10229813 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 35275879 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 23720426 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 21036625 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 17702987 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 28570668 | ||
| Pubmed | UBR4/POE facilitates secretory trafficking to maintain circadian clock synchrony. | 4.74e-05 | 2 | 240 | 2 | 35332162 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 18096135 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 11397869 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 15618253 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 15670752 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 15028716 | ||
| Pubmed | IKK promotes naïve T cell survival by repressing RIPK1-dependent apoptosis and activating NF-κB. | 4.74e-05 | 2 | 240 | 2 | 37368952 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 16979925 | ||
| Pubmed | Identification and characterization of GSTT3, a third murine Theta class glutathione transferase. | 4.74e-05 | 2 | 240 | 2 | 12038961 | |
| Pubmed | CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. | 4.74e-05 | 2 | 240 | 2 | 19401689 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 23691008 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 17942909 | ||
| Pubmed | The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. | 4.74e-05 | 2 | 240 | 2 | 20739949 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 27974825 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 8384312 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 25022956 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 25766330 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 19797068 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 23632327 | ||
| Pubmed | Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2. | 4.74e-05 | 2 | 240 | 2 | 12239185 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 8418200 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 9160743 | ||
| Pubmed | Nuclear factor kappa B and cyclo-oxygenase-2: two concordant players in psoriasis pathogenesis. | 4.74e-05 | 2 | 240 | 2 | 25215902 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 19616539 | ||
| Interaction | NPTN interactions | ATR SARM1 RUSC1 MDN1 XPO6 NBEAL2 MMS19 ARFGEF1 GEMIN5 HUWE1 ARFGEF3 EXOC5 THADA HEATR6 MROH1 HTT | 8.42e-08 | 278 | 222 | 16 | int:NPTN |
| Interaction | TOP3B interactions | ABCC3 PIEZO1 TMC6 CUL9 ZZEF1 BIRC6 LYST RYR1 BAP1 FAM20C URB1 DST MDN1 PIK3C2B XPO6 NBEAL2 CSAD PKD1 MMS19 HERC1 DOCK6 PREX1 IQGAP3 SEMA4F ATP13A1 UBR4 ZDHHC7 GEMIN5 TTYH3 HUWE1 SYNE4 THADA TKFC AATK MROH1 DISP2 PRKDC HTT PPP1R16A | 2.52e-07 | 1470 | 222 | 39 | int:TOP3B |
| Interaction | C3orf18 interactions | 5.84e-07 | 115 | 222 | 10 | int:C3orf18 | |
| Interaction | GPR17 interactions | ATR SLC38A9 URB1 MDN1 XPO6 VPS8 ARFGEF1 CERS6 TTYH3 ARFGEF3 EXOC5 THADA PRKDC DGAT1 HTT | 6.18e-07 | 283 | 222 | 15 | int:GPR17 |
| Interaction | GPR182 interactions | ATR NCKAP1 TMC6 SREBF2 URB1 MDN1 XPO6 NBEAL2 MMS19 AHCTF1 ARFGEF1 ARFGEF3 EXOC5 THADA HEATR6 MROH1 PRKDC DGAT1 HTT | 7.57e-07 | 455 | 222 | 19 | int:GPR182 |
| Interaction | CXCL5 interactions | 1.03e-05 | 27 | 222 | 5 | int:CXCL5 | |
| Interaction | TACSTD2 interactions | 1.33e-05 | 129 | 222 | 9 | int:TACSTD2 | |
| Interaction | OPALIN interactions | ATR MDN1 XPO6 ATP13A1 AHCTF1 ARFGEF1 USP46 THADA HEATR6 MROH1 PRKDC | 2.14e-05 | 209 | 222 | 11 | int:OPALIN |
| Interaction | RNF123 interactions | OR5M10 TOPAZ1 ITGAE ZZEF1 BIRC6 RYR1 FAM20C URB1 DST MDN1 NFKB1 PKD1 MTCL1 SEMA4F UBR4 DNAH2 ST3GAL4 HUWE1 SPATC1 GIMAP8 TM2D2 PRKDC CXCR2 | 4.28e-05 | 824 | 222 | 23 | int:RNF123 |
| Interaction | CD40 interactions | 5.13e-05 | 153 | 222 | 9 | int:CD40 | |
| Interaction | TSPAN15 interactions | PIEZO1 TMC6 ADGRE2 RTN2 C3AR1 ATP13A1 MFSD9 CERS6 SYNE4 KRTCAP3 ALG3 DGAT1 | 5.94e-05 | 276 | 222 | 12 | int:TSPAN15 |
| Interaction | CLEC2D interactions | SLC16A13 SLC39A1 SEMA4F AHCTF1 ARFGEF1 TMEM9B ARFGEF3 HEATR6 MROH1 MFSD3 | 6.89e-05 | 197 | 222 | 10 | int:CLEC2D |
| Interaction | HLA-B interactions | ATR MDN1 ANTXR1 MMS19 AHCTF1 ARFGEF1 HUWE1 HEATR6 MROH1 PRKDC HTT | 7.27e-05 | 239 | 222 | 11 | int:HLA-B |
| Interaction | C1orf87 interactions | 7.40e-05 | 21 | 222 | 4 | int:C1orf87 | |
| Interaction | FXYD3 interactions | 8.14e-05 | 94 | 222 | 7 | int:FXYD3 | |
| Interaction | NPY2R interactions | 8.74e-05 | 66 | 222 | 6 | int:NPY2R | |
| Interaction | HCST interactions | 9.59e-05 | 205 | 222 | 10 | int:HCST | |
| Cytoband | 8q24.3 | 3.04e-05 | 113 | 240 | 6 | 8q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 7.88e-05 | 134 | 240 | 6 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 2.82e-04 | 316 | 240 | 8 | chr3p21 | |
| Cytoband | 15q15.3 | 2.98e-04 | 25 | 240 | 3 | 15q15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | OR7G1 OR7C1 TICAM1 ADGRE2 ADGRE3 ADGRE4P DOCK6 OR7G3 OR7G2 ATP13A1 SH2D3A TNFAIP8L1 RASAL3 | 3.27e-04 | 797 | 240 | 13 | chr19p13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 5.38e-04 | 71 | 240 | 4 | chr1q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.09e-03 | 147 | 240 | 5 | chr15q15 | |
| Cytoband | 9q33.2 | 1.12e-03 | 39 | 240 | 3 | 9q33.2 | |
| GeneFamily | Olfactory receptors, family 1 | 1.80e-06 | 40 | 169 | 6 | 147 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 7.91e-06 | 5 | 169 | 3 | 915 | |
| GeneFamily | Dyneins, axonemal | 4.95e-04 | 17 | 169 | 3 | 536 | |
| GeneFamily | Parkinson disease associated genes|Ubiquitin C-terminal hydrolases | 5.15e-04 | 4 | 169 | 2 | 998 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 8.19e-04 | 78 | 169 | 5 | 262 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | CD109 ADGRE2 ITGAE ITGAM LAIR1 LAIR2 TLR2 FCRL4 ACKR1 CXCR1 CXCR2 | 1.22e-03 | 394 | 169 | 11 | 471 |
| GeneFamily | CD molecules|C-X-C motif chemokine receptors | 1.27e-03 | 6 | 169 | 2 | 1094 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.99e-03 | 9 | 169 | 2 | 1230 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | NHSL2 LRRK2 PTGS2 XPO6 PREX1 ST3GAL4 OSM TLR2 IL1RN CXCR1 CXCR2 | 2.12e-09 | 170 | 238 | 11 | 151dabe1d240dde414c881bf4fa816c69fa1c32d |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | NHSL2 LRRK2 PTGS2 XPO6 PREX1 ST3GAL4 OSM TLR2 IL1RN CXCR1 CXCR2 | 2.40e-09 | 172 | 238 | 11 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 |
| ToppCell | PSB-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | LRRK2 ADGRE2 ITGAM PTGS2 ADGRE3 C3AR1 OSM TLR2 IL1RN CXCR1 CXCR2 | 7.60e-09 | 192 | 238 | 11 | 8dbdaa6a81767a866fb856f99ae35f9ee8064106 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | KLHL32 ADCY5 DST GPR62 CAPN3 PAQR8 ST3GAL4 ARFGEF3 AATK USP54 TMEM151A | 9.93e-09 | 197 | 238 | 11 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd |
| ToppCell | critical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | LRRK2 ADGRE2 LYST PTGS2 C3AR1 PREX1 OSM TLR2 IL1RN CXCR1 CXCR2 | 1.05e-08 | 198 | 238 | 11 | 4da73dc3acb29d70b160903600d2bf7fdab34333 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NHSL2 LRRK2 ITGAM LYST GADD45G ARFGEF1 OSM IL1RN PPP1R42 CXCR2 | 3.21e-08 | 172 | 238 | 10 | d354424c1f861b6607dfd63b9724f4c237b30275 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ABCC3 PDE1B CD109 SERPINF2 IQGAP3 PAQR7 USP30 DNAH1 GIMAP8 RSKR | 8.21e-08 | 190 | 238 | 10 | 63018acb7ad80415e861643162abdc2e55968ee4 |
| ToppCell | NS-moderate-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.06e-08 | 192 | 238 | 10 | 545c3990cbe3c04bfd95a0ab7499d2c4af509be1 | |
| ToppCell | moderate-Myeloid-Neutrophil|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.06e-08 | 192 | 238 | 10 | 8105408400dac5dcb0ce62b558433257559c9f09 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Neutrophil|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.06e-08 | 192 | 238 | 10 | 3db74359c30172a51177e00eac1f48f483e15578 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | LRRK2 ADGRE2 PTGS2 SLC26A8 XPO6 ADGRE3 TLR2 IL1RN CXCR1 CXCR2 | 9.98e-08 | 194 | 238 | 10 | eb23b171e429165dd26a64377eae7fa2ce25f547 |
| ToppCell | NS-critical-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-07 | 197 | 238 | 10 | f38037dfa6c33e9336130d0cc65eaba0f120efb9 | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.21e-07 | 198 | 238 | 10 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | NS-critical-d_07-13-Myeloid|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-07 | 198 | 238 | 10 | 08bc3f63a5c5b65bff10aadebdaa5e7f192cda01 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-07 | 199 | 238 | 10 | 8c2ab13b5fffbab3da37041a7000d6537fc4db09 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-07 | 200 | 238 | 10 | 390f9429feae991b8524e2815d8fcd4914c74459 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-07 | 200 | 238 | 10 | fd1b6db3c62f5a205b769ba0e61433dae6285b67 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-07 | 200 | 238 | 10 | f7e9b4a8ededb116774528b38ea3381b6f05915c | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-07 | 200 | 238 | 10 | d98c523ac0e4767aaeef50cae142513d115212ab | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-07 | 200 | 238 | 10 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.33e-07 | 200 | 238 | 10 | 1592ca96c59eb053d0f0915afb337db9f3a40c91 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-07 | 200 | 238 | 10 | c325dc52e4bf3829a35905b956784ca3e9191926 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-07 | 200 | 238 | 10 | 0b7573ec4e9c67c7d11dd8f5011a70bade30e930 | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-07 | 153 | 238 | 9 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-07 | 153 | 238 | 9 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-07 | 161 | 238 | 9 | 65888250b8c1da6a8f9b5376e086a3769a1cbbd8 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-07 | 166 | 238 | 9 | 5126d8f02314717eed341d867856fd4fe16c5118 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-07 | 166 | 238 | 9 | 3037bdca38c3a65eacfa644219cc43c54e303749 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-07 | 170 | 238 | 9 | 8fd0a55266066a51266ab616c38c883e2680bcf4 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-07 | 171 | 238 | 9 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-07 | 171 | 238 | 9 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-07 | 172 | 238 | 9 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-07 | 172 | 238 | 9 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-07 | 172 | 238 | 9 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-07 | 174 | 238 | 9 | 4b749ac9f05776c0c56b74daca833bd0b5704299 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-07 | 175 | 238 | 9 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-07 | 176 | 238 | 9 | f7d8eb90489a6d22240179abeb0aa16ac24615d3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.95e-07 | 181 | 238 | 9 | 1110a0375189c034e6b02e6ebceb7084e4590114 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.52e-07 | 183 | 238 | 9 | aed12b743334f3813db0c70d4fe7df90e0673f54 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.14e-07 | 185 | 238 | 9 | 00a991e63e9ac6de3f48a96e3be6073f90cbb442 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | IFT140 SLC38A9 CD109 SLC22A17 PIK3C2B PREX1 CCNJ GIMAP8 ALG3 | 7.81e-07 | 187 | 238 | 9 | 3699d5e71d779da922920aa3160895db187bf81b |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | IFT140 SLC38A9 CD109 SLC22A17 PIK3C2B PREX1 CCNJ GIMAP8 ALG3 | 7.81e-07 | 187 | 238 | 9 | 033ba52c0c2f9978784947098fa697368ae44834 |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-07 | 187 | 238 | 9 | 75bc05a0ba2727fecc236903ace792a28f3d3c9a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.81e-07 | 187 | 238 | 9 | a0d59bf1043ff5a1e8110b39ecc2d3932675edd4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 8.54e-07 | 189 | 238 | 9 | a62f4c445ede00d15b74bee65f4e4fb54cfd4d32 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.54e-07 | 189 | 238 | 9 | f6b2b4824505f0119a017fdb73c55418fb651645 | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.54e-07 | 189 | 238 | 9 | fedab592be1d6520325b8c1b659b0a4dc3f4fe4d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.54e-07 | 189 | 238 | 9 | 235c24eeab5139f5821fccd5c879d8787682f4ef | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.54e-07 | 189 | 238 | 9 | db8e314ce95c32542bb4015a77032a33211fea0b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-07 | 191 | 238 | 9 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.73e-07 | 192 | 238 | 9 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-06 | 196 | 238 | 9 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-06 | 196 | 238 | 9 | d9b5eaca4089d5337f1175a663418c9c675cdd87 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-06 | 196 | 238 | 9 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | Monocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.15e-06 | 196 | 238 | 9 | 7bc0735d324ac5a1661434cda4116ddd58296730 | |
| ToppCell | BL-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.20e-06 | 197 | 238 | 9 | 932a7fae4979b561688e6222505df0f4e510ab11 | |
| ToppCell | mild_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 1.20e-06 | 197 | 238 | 9 | 63e7b040c64f1e28b8db79980c7b580caa7d1b95 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-06 | 197 | 238 | 9 | 037f5f26fa66818baa35846aa96336155e8a6f45 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.20e-06 | 197 | 238 | 9 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | critical-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-06 | 197 | 238 | 9 | f1248781e71e3a158d06e9ec93eb90dc6d48bcb2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-06 | 197 | 238 | 9 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | NS-critical-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.26e-06 | 198 | 238 | 9 | 72d51284d267f102c26f0ae8279ee9e11e69c7e3 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-06 | 198 | 238 | 9 | c65103828a4755fcf3c0776c60d8ada1f0ad5278 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-06 | 199 | 238 | 9 | 76aab03a51681f0ce3369887cf71a884b0998ec5 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|Control_saline / Treatment groups by lineage, cell group, cell type | 1.31e-06 | 199 | 238 | 9 | e1240bfcdce76ec018599c50350748f9c7b8fb0e | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 199 | 238 | 9 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-06 | 199 | 238 | 9 | 7227e6be56e9f333ee143e1418d22de32a4ca66a | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 148 | 238 | 8 | 003e10bf477984248211b99d75daa8f7dcdb12c8 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.37e-06 | 200 | 238 | 9 | 59b2ebb69699c9bebf8c2697eb678fdccd0a998c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 200 | 238 | 9 | 1a080564de59abd59d3208a73441b6346e1c7cd8 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 200 | 238 | 9 | 3504aeba7b30cac9c428ba3871c072e2202752b4 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 200 | 238 | 9 | 09bac15df511687ff336c1e7a67d980c6c281f79 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 200 | 238 | 9 | c5afebbc16024c60e84a67be81c78b0bfb73ec68 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 159 | 238 | 8 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-06 | 162 | 238 | 8 | f24eb596653180040bfdefad9c246fc42cbfaac8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-neutrophil-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-06 | 162 | 238 | 8 | 1a953e165b7e469815294728350ec13d27c9bd9d | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 164 | 238 | 8 | a27b9b3380f29bb17c9f787423f2591f2b9cf33e | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 165 | 238 | 8 | 680bdd150bc0a4e50244e57b1226a9b06a6bdbc9 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 165 | 238 | 8 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 165 | 238 | 8 | af423307af484661284793a08091777d998e6fba | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 165 | 238 | 8 | a761e0a36d5da8fec916d684f81e60f5590fd9ee | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 166 | 238 | 8 | 019d365df44c3bbd88c1f4bdceb3de0ff76d3e8d | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-06 | 166 | 238 | 8 | 6b6ecd70264b6bfbd8a3a378c965702829e2ecf1 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-06 | 166 | 238 | 8 | 3195035445d35d820f5e00dd03b029730478b024 | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-06 | 118 | 238 | 7 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-06 | 118 | 238 | 7 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 169 | 238 | 8 | d3e6c75e5eda133fb6535cfe6c6a1026641f26ac | |
| ToppCell | Monocytes-IFN-activated_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.99e-06 | 171 | 238 | 8 | df1b631618839bee4a18a2ba9c730321e5015f36 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-06 | 171 | 238 | 8 | 187b396059f8802265f54bad2b4882cebb809419 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-06 | 177 | 238 | 8 | 7853430fb0d1a18d835e8956777e0616c5d7d412 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 177 | 238 | 8 | ed44b1bf2ffae97f94e944d1b6060d5163eba6a6 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-06 | 177 | 238 | 8 | 9a5bf67a801826d094f679dd2189b62296c9694f | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-06 | 177 | 238 | 8 | 395f005f019aabb18738d3a10a04c37f216deda3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.37e-06 | 178 | 238 | 8 | 94a86f5232fffa6a92a30ea21fb44eec33b4d6c8 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.32e-06 | 182 | 238 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.32e-06 | 182 | 238 | 8 | 1932d77491d6d46278f01fd70eb469ef1b356619 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.32e-06 | 182 | 238 | 8 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.32e-06 | 182 | 238 | 8 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.58e-06 | 183 | 238 | 8 | 340621a8e720bd98da335f90598096833681834c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.58e-06 | 183 | 238 | 8 | 75da8c05b6d636f434c5684e0166fed0de3547b4 | |
| Disease | myeloid white cell count | NRIP1 SLC38A9 PIEZO1 ETF1 FAM200A ADCY5 XPO6 TGFBRAP1 NFKB1 PKD1 PREX1 VAV2 ATP13A1 VPS8 THADA SPAG17 ACKR1 IL1RN MFSD13A HTT CXCR1 CXCR2 | 3.87e-06 | 937 | 227 | 22 | EFO_0007988 |
| Disease | pyelonephritis (is_marker_for) | 1.54e-05 | 7 | 227 | 3 | DOID:11400 (is_marker_for) | |
| Disease | monocyte percentage of leukocytes | NRIP1 PIEZO1 ADCY5 FBXL18 TGFBRAP1 NFKB1 C3AR1 CAPN3 GPR88 THADA RASAL3 PEDS1 PRKDC ACKR1 IL1RN CXCR1 CXCR2 | 5.70e-05 | 731 | 227 | 17 | EFO_0007989 |
| Disease | level of protein AMBP in blood serum | 5.89e-05 | 2 | 227 | 2 | OBA_2040579 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 5.89e-05 | 2 | 227 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 5.89e-05 | 2 | 227 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | osteoporosis (is_implicated_in) | 9.12e-05 | 31 | 227 | 4 | DOID:11476 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALLLLLSACLAVSAG | 6 | P02760 | |
| ALSILVLLQAGSLHA | 11 | P06881 | |
| LAIVALAVCAALHAS | 6 | Q9NRJ3 | |
| VLTLALLGNAHACSK | 6 | P11597 | |
| HCSDGSILAIALLIL | 316 | Q9H6X2 | |
| IGALHLILVCLSALS | 4241 | Q9NR09 | |
| SGICVVLNLAELNHL | 261 | Q9UKL4 | |
| LSVALALSHLALGAQ | 111 | P08697 | |
| LHLQLSLCLFLAHLL | 571 | Q9UHX3 | |
| SLCLFLAHLLFLVAI | 576 | Q9UHX3 | |
| SQQLFKLLDCLLESH | 1676 | Q9Y6D6 | |
| SAALHICHAVILLQL | 406 | Q92685 | |
| LLVLATICLAHALTV | 101 | Q9HD20 | |
| VLHICLAFCSLLLFS | 6 | Q86TY3 | |
| LLSALLLAVALLFHC | 396 | Q96PJ5 | |
| VLLTTHNLAEAEALC | 1466 | Q8N139 | |
| LCLFLAHLLFLTGIN | 231 | Q86SQ3 | |
| DISIQQLHLVALSCL | 76 | Q5T5M9 | |
| QLHLVALSCLLLASK | 81 | Q5T5M9 | |
| VALRHCLALLVLSAA | 356 | Q12887 | |
| LIPNSCATHALLSVL | 86 | Q92560 | |
| LNLAEALAILHCVAT | 286 | Q16570 | |
| ALAILHCVATPLLLA | 291 | Q16570 | |
| VLSGVLLSALHLAIA | 351 | O95622 | |
| LLHVANLATILCFPA | 166 | O75907 | |
| FLHLTLADLLCCLSL | 61 | Q16581 | |
| AALLLLSSVCANHTL | 546 | A7MBM2 | |
| DLLCCLNLNSHITGL | 171 | Q8TCP9 | |
| DLQTAILLLAHGSCE | 576 | Q5VW22 | |
| ALQLAVLHAQLCTIF | 701 | Q86YV0 | |
| ATLLALCVQHSAREL | 576 | Q5U651 | |
| LLTFHLSFCGSLEIN | 161 | Q6IEU7 | |
| ELFLLLCAILQHFNL | 446 | P05181 | |
| ALLSNIQRCDLAAHL | 721 | Q9Y4B5 | |
| IHFALVLSALILACF | 176 | O15438 | |
| SALSQTLLCHLLILV | 171 | Q6P4D5 | |
| LLLLLICFNVGSGLH | 11 | Q14126 | |
| LILQLSCSDTHLLEL | 181 | A6NIJ9 | |
| SCSDTHLLELIAFLL | 186 | A6NIJ9 | |
| GNLLILLAIGSDHCL | 41 | Q8NHA8 | |
| QLFHIFLVLCTLAQL | 276 | Q86WK9 | |
| AQCLLLSLLLLAASE | 11 | Q9Y5H8 | |
| RLLGSQLLACTLSHN | 3681 | Q9NU22 | |
| LGHCDVLLSLRLLEN | 86 | Q9NPI8 | |
| LAHLCVVDLLAAASI | 51 | Q9BZJ7 | |
| LAAAALLAQTALLLH | 196 | Q9GZN0 | |
| HLALLDEISTCHQLL | 451 | Q8IXH7 | |
| QALLLHSSILTCTLL | 351 | Q8NBP5 | |
| LCDALLHPNCTLISL | 766 | P59045 | |
| LLSQVLLHCHTLLLE | 71 | Q96T76 | |
| LLHCGRFQDALESLL | 5391 | Q03001 | |
| INRSLLALGHCISLL | 286 | Q96FN5 | |
| ALAVLLLAAGLAAHL | 636 | O75325 | |
| TALLGLVLCLAQTIH | 6 | Q6GTX8 | |
| HGLADLSELQLRTLC | 2286 | Q15751 | |
| CLASLAVGLHLDQLL | 3886 | Q15751 | |
| LLCLLLALFASGLIH | 76 | Q8N6L1 | |
| NHLDSHLLLCFVGLA | 136 | Q8NA75 | |
| AVVLSLLIALAAKCH | 41 | Q8IVY1 | |
| TLLCIASLALLAAFN | 6 | P38570 | |
| LSNALVLLCLLHSAD | 21 | Q8NDV2 | |
| LSGNAVLILLIHCDA | 71 | Q8NH00 | |
| HCLSEIELLAIIFAA | 246 | Q01064 | |
| LVTLLCHLFNTHGLI | 131 | Q9NP56 | |
| LDATEILGILHSCLN | 296 | P25025 | |
| LLLLTNHRVLSCGDN | 36 | Q8IVU3 | |
| LHSLLEANCSLALAE | 6 | Q13324 | |
| QICQALIHLLSLASA | 1071 | Q6AI08 | |
| ILCFSLIAHNLVHLL | 51 | A5PLL7 | |
| SLNQGLSLLLHELLC | 326 | Q96LW2 | |
| AALQISALSCLALLT | 306 | Q5S007 | |
| VACSQLALLLSSEAH | 261 | P48552 | |
| LLLCAVLALSHTANP | 6 | P35354 | |
| LALSCNRHLTSLNLV | 1116 | P59047 | |
| LIFHSVALCLASLNS | 271 | Q9BXC1 | |
| IACACALLHTLLLAQ | 151 | Q8NGS3 | |
| ALLHTLLLAQLSFCA | 156 | Q8NGS3 | |
| LLLAQLSFCADHIIP | 161 | Q8NGS3 | |
| LDALLAALHSQICVP | 306 | Q8NDA8 | |
| CLLLHLLLSGACTQF | 151 | Q86SM8 | |
| NHIRLSCLAVGLALL | 681 | P78316 | |
| LGAELCQEAHSIILS | 201 | P0CG30 | |
| LDHEALSCLLVLLFV | 3181 | Q7Z6Z7 | |
| ILRGSALLSLCLQHF | 316 | Q96ES6 | |
| ALLSLCLQHFLGGLV | 321 | Q96ES6 | |
| LLLNSHLCVALLEGE | 166 | Q8WXE0 | |
| CIHALSLFLFRLGLA | 141 | Q86VI3 | |
| ALNSLHCGALTLLPL | 106 | Q6UXB3 | |
| FILCHGILNTDATAL | 266 | Q9Y2A7 | |
| ALSHTLLLAQLSFCA | 156 | Q8NGS1 | |
| SLLHILLTNQLIFCA | 206 | Q8NH94 | |
| HTHLFLNLLGLMLSC | 1271 | O00750 | |
| LALILELLTFCIQHH | 511 | Q6ZMV5 | |
| LLALLALAALCIAGQ | 6 | P02818 | |
| LSVTILLLNFLRSHC | 56 | Q9UBM1 | |
| GNLLILLAVISDSHL | 41 | Q8NGA0 | |
| HAFLSICTLSQLEAI | 286 | Q8TEZ7 | |
| LLAISCSDTHVIQLL | 196 | Q8NG75 | |
| GNLLIILAICSDSHL | 41 | O76099 | |
| CHLLVLSLALADSGI | 51 | P47804 | |
| SALSCLLLHLLVLCL | 6 | P55075 | |
| LLLHLLVLCLQAQEG | 11 | P55075 | |
| SLLLSLCLFHGNALE | 3816 | Q9P2D7 | |
| LHLFDTLHALCNLLV | 651 | O00471 | |
| ILLFSCALALHARQV | 791 | Q08828 | |
| ACLGSLLSHVIVALL | 1206 | Q13535 | |
| LLTAAHLLCVCTAAL | 6 | Q6YHK3 | |
| HLLLLLLLSAAVCRA | 11 | Q9NYL4 | |
| RTVLHANLAACQLLL | 251 | Q9UIM3 | |
| LVHCVRLLSASFLLT | 681 | P42858 | |
| ALVAVLLLAACHLAS | 26 | Q96PB1 | |
| QHFLAGLLLTELALA | 1106 | Q96HP0 | |
| LCLTFLLLHLLGQVA | 16 | P48745 | |
| LHTACLNLDSNLRLS | 266 | H7BZ55 | |
| TALLSILNFCSELQH | 441 | Q9UKA2 | |
| ILNFCSELQHLSLGS | 446 | Q9UKA2 | |
| VFLVACALHIALDLL | 16 | Q8IXL6 | |
| LSLNQSHIHSLLLCG | 696 | Q5T0N1 | |
| LHELLLSAQRQGCLT | 26 | O95257 | |
| TAAHCALLLNLKLSH | 736 | Q5TH69 | |
| LLSHCLLVTLAAHLP | 101 | P69905 | |
| LGAELCQEAHSIILS | 201 | P0CG29 | |
| LLCLVLLSPQGASLH | 6 | P05154 | |
| LQTLHLQSCDLLDIF | 176 | P86791 | |
| LFSFCLTINLLLHER | 3281 | Q8WXX0 | |
| CLELSAPSLHALLLV | 86 | Q8ND71 | |
| ALDATEILGFLHSCL | 286 | P25024 | |
| HPSCLLALLVAGLAQ | 6 | P56202 | |
| SGCLHLVSDLLQALF | 111 | Q9NSG2 | |
| LQTLHLQSCDLLDIF | 176 | P86790 | |
| GTLVLCLHDSADALL | 231 | Q6ZMG9 | |
| LLAAGLQCSALLLQD | 306 | Q9Y600 | |
| NNSPFDLCHVLLSLL | 251 | Q99698 | |
| CALVSLATAALLGHI | 16 | P10253 | |
| DLLALDTGHCNDLLI | 321 | Q8N7A1 | |
| LLLLNLLLCNHHTLG | 871 | Q8IWT3 | |
| ACAVLAVHLNTLLGE | 76 | P40121 | |
| LITLLLFLFHSETIC | 11 | P18510 | |
| LHLLQLAFGNRKCLA | 301 | Q8WYP5 | |
| FLAAIACLTLNQHLL | 131 | P20807 | |
| SVVAHQILCILSALA | 1866 | Q9P225 | |
| QILCILSALAAGLTH | 1871 | Q9P225 | |
| LTLAFFIHNCIITLL | 366 | Q8NBW4 | |
| CLSLLHTLVAFLCII | 4646 | P21817 | |
| LLNVCFLSTGVAHSL | 426 | Q96RY7 | |
| HLSLLCLFIASNRVF | 356 | Q14CX5 | |
| SDHICLSDLIAAGIL | 261 | Q6ZN68 | |
| LALALVNLLLSVACS | 96 | Q53RY4 | |
| TALLGLVLCLAQTIH | 6 | Q6ISS4 | |
| LLTSVCLLLFAVHFA | 3901 | P98161 | |
| ALLHTVLIAQLSFCA | 156 | Q15619 | |
| CLAVLQALSVLHAQG | 421 | O96013 | |
| SLLHVLLVNRLTFCT | 156 | Q8NH93 | |
| QLLTLACTDTHILGL | 181 | Q8NH72 | |
| ACTDTHILGLLVTLN | 186 | Q8NH72 | |
| SLNLDIQALACLSAL | 526 | Q92570 | |
| LVLTTLCPALHALVA | 526 | Q9BVN2 | |
| IVSVAAHLALLLLCG | 376 | O75298 | |
| VLLCLSISRLFLHGL | 56 | P59533 | |
| AVCLAPSLFHLNLLK | 811 | Q9Y3M8 | |
| ASLLLHCVQLTDGVS | 36 | Q6YHU6 | |
| IALALALAVLCDLLQ | 1776 | Q6YHU6 | |
| VQILAIANASHLLTC | 126 | O95754 | |
| GRTVAACDLLQSLLH | 256 | Q9HBY8 | |
| AALLCLSALLAHASG | 11 | Q6IEE7 | |
| VLEAEQNSLHLCLLG | 101 | Q8N205 | |
| GAFLQHVVLAACALL | 471 | Q8WUG5 | |
| HVVLAACALLCILSI | 476 | Q8WUG5 | |
| HSDLALRNCLLTADL | 251 | Q6ZMQ8 | |
| LLRQLADLCGHSLAL | 36 | Q5HYW2 | |
| CLLPFCSLHLHLQLS | 541 | Q9UPU3 | |
| LCSLGLLVTAIFTDH | 16 | Q8NBL3 | |
| NANILILIAGCHSSI | 751 | Q96RN1 | |
| LLTFHLSFCGSLEIN | 161 | Q8NGP8 | |
| GNLLILLAVISDSHL | 41 | Q8NG99 | |
| LAHILKLACSDVLIN | 181 | Q8NG95 | |
| LCHLEQLLLVTHLDL | 456 | Q92696 | |
| ALCLDKSLIHTVLLQ | 61 | Q96ME1 | |
| LENVALHALLLCEGL | 131 | Q6ZNJ1 | |
| LLALLHGSLVQESLA | 1136 | Q6ZNJ1 | |
| LHSLAKSLCILNISN | 141 | Q7Z4L9 | |
| VAATGVLLHCQSLLS | 1371 | Q8TCU6 | |
| HLVELLIASGANLLA | 151 | Q96I34 | |
| TLLTLAALNCLGLLH | 196 | P08842 | |
| TGLLAITLALHLCDL | 261 | Q11206 | |
| HLLKQDCLTEALALA | 506 | Q8N3P4 | |
| CLILSDELNHTSLVL | 246 | Q9NUV7 | |
| LLLTLLIHACGAVVA | 46 | Q8N4L1 | |
| LSLHSLFELRSCLIN | 161 | Q2Y0W8 | |
| INLLQTLCLSAGVHA | 696 | Q9BVR0 | |
| LLLTALTLCHGFNLD | 6 | P11215 | |
| LIALLCSTLLHGLGN | 196 | Q8NH09 | |
| QALHQCSRIDLLSSL | 651 | Q13546 | |
| LSIAALLLQESCTHL | 1231 | O60287 | |
| LQTLNATLGCVLHRL | 96 | P13725 | |
| QAALFLGTLHLQCSE | 1616 | Q7RTU9 | |
| PDLCVNLLLALNLHL | 551 | Q9NZQ3 | |
| AAHIVSLLPSLCLSE | 481 | Q6Q759 | |
| LHLQLSLCLFLAHLL | 391 | Q9BY15 | |
| ALAAALHYALLSCLT | 316 | Q8IZF4 | |
| ALSILVLLQAGSLHA | 11 | P01258 | |
| LSIPLAFACLLHLAN | 706 | Q15003 | |
| EALHSCLQILIALLG | 146 | Q8IVV8 | |
| AHITALKSLGCFLLL | 216 | Q9NYW4 | |
| LGLNLALSSCHVDLL | 346 | Q8N2E2 | |
| LAVAVDGHFLCLALT | 171 | Q8WUH2 | |
| HDSLLDLLVTENFCL | 461 | Q8WUH2 | |
| QAALLLGNLLLLHCV | 16 | Q9BX73 | |
| LFVLHLALTDLAVAL | 71 | P47901 | |
| AFHLLLVCLSPALLS | 6 | P0DPA2 | |
| SLSCLALSVLLLAQL | 16 | Q9NQ34 | |
| IVFNLLAFLALASHC | 81 | Q9NYG2 | |
| SLLLVSALSLHLVAC | 171 | Q7RTY0 | |
| NHAGLLQTVFVSCLL | 81 | Q6ZMD2 | |
| SLQALLHSPSVLVCA | 206 | Q8IWN7 | |
| LRLHACLAVAVLATN | 266 | Q6SZW1 | |
| RVLDVQLCACSLLLH | 381 | Q8NE28 | |
| QLCACSLLLHLLGQA | 386 | Q8NE28 | |
| LLLLSCLSQLAHDDG | 571 | Q76KD6 | |
| SALRACVLVFSLALH | 176 | Q9NY26 | |
| STALHLLLVDCQATG | 316 | Q9BRG2 | |
| CLQDAIDHSAFIILL | 441 | Q8IUC6 | |
| DLRVFLSCLSSHLQA | 366 | Q6ZV50 | |
| AAAILAANTLHSCLR | 131 | Q96MI6 | |
| QLLLPVLLACAAHST | 11 | P47872 | |
| LLHVGASAICCLLLS | 66 | A6NH21 | |
| ALNHVVQLLTCDLLL | 966 | Q12772 | |
| LLHICHDLTLAVLSQ | 1201 | Q8TEQ6 | |
| GLSLSALQDLCRELH | 56 | P19237 | |
| VCTLLLAAHLLGDQI | 281 | Q9NQQ7 | |
| SFLLAVVCLLQLAHL | 81 | Q9HBU9 | |
| EAIIHGLSSLTACQL | 106 | P54274 | |
| LASCLTFLLSLPHNI | 726 | P78527 | |
| VLNDLLNSLLKHCLL | 1166 | Q8N9V7 | |
| LLTCLADLFHSIATQ | 76 | P62068 | |
| TSCLIEHLNILLFGL | 1301 | Q86YA3 | |
| LPALSCVQTALLHLL | 1671 | O43149 | |
| FNCLAVLALSSHLRT | 86 | Q9NXF8 | |
| LRSALLLEQAAHCFI | 536 | Q9Y2L5 | |
| LSLTLLHLLKALSCQ | 116 | Q70CQ3 | |
| LVSVALELLCFLLHL | 236 | Q7RTT9 | |
| LFLGTLHLQCSEEQL | 1616 | A6NGW2 | |
| LALHSLGLALLSALQ | 211 | Q7Z403 | |
| FSLLCTLAHFVINIL | 266 | Q9H598 | |
| LSLLFLVAHLALQIC | 66 | Q92508 | |
| ALRDGVLLCQLLHNL | 36 | P52735 | |
| AISLLCASFNRGIHL | 336 | Q8NA23 | |
| DKLLLSACHLLVSLA | 671 | Q96QU8 | |
| VCSTLLGLEEHLNAL | 381 | Q3LXA3 | |
| LHIVLLSSLDVLCLG | 181 | Q9BXE9 | |
| LLHLCGSLAQLACVE | 1446 | Q5T4S7 | |
| QALLLLGAAALACLA | 41 | Q9C0H2 | |
| CALFLLILLTGVLCH | 596 | O60603 | |
| CLLHLLEASERQSLA | 376 | A8MYJ7 | |
| LAAGLLECRDLLHQA | 116 | Q8WVP5 | |
| ACALLLLFPLTAQHE | 46 | P09936 | |
| ALCNEAISKLRLALH | 821 | Q70EL1 | |
| SFLLGLSHLVLCCLL | 6 | Q8N9W7 | |
| LSHLVLCCLLTFIVN | 11 | Q8N9W7 | |
| SFLLGLSHLVLCCLL | 6 | A6NDX4 | |
| LSHLVLCCLLTFIVN | 11 | A6NDX4 | |
| LCDNKFHTEALTALL | 126 | P62495 | |
| LAAGSHLQLLELLNL | 116 | Q96NJ5 | |
| LAVEHDNISLAGCLL | 691 | P19838 |